The results showed that there were significant differences in ALT, AST, triglycerides, Non-HDL cholesterol, body mass index, uric acid, Log SII, BUN, and poverty income ratio between the Non-NAFLD group and NAFLD group (Table 1, all p < 0.05). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.